secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001471727-22-000092
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice Q3 net sales $11.9M (-10% YoY); net loss $6.5M vs $3.5M
---------------------------------------------------------------------

- Net sales $11.9M, down from $13.2M in Q3 2021; YTD net sales $45.4M, up 30% YoY.
- Gross margin improved to 35% (adjusted 37%) from 29% in Q2 2022; loss from operations $6.4M.
- Extended revolving credit facility to $13.5M, removed going concern language from 10-Q.
- Adjusted EBITDA loss $2.9M vs $1.4M loss in Q3 2021; net loss $6.5M vs $3.5M.
- International net sales up 31% YoY; domestic softness due to channel destocking.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000147172722000092/0001471727-22-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000147172722000092/bttr-20221110.htm
  HTML page:      https://secwatch.observer/filing/0001471727-22-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer